Biotech · Private company
Rapa Therapeutics LLC
Track this companyFree. Adds Rapa Therapeutics LLC to your Dealase workspace and tells you when its record changes.
Clinical trials63 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- RAPA-501 Autologous T stem cellsPhase 3 · Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Chemotherapy Prior to RAPA-201 TherapyPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Chemotherapy Prior to RAPA-201 TherapyPhase 2 · Malignant Melanoma With MetastasisClinicalTrials.gov · fetched Nov 12, 2026
- Pembrolizumab (PD-1 Blocking Antibody)Phase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- RAPA-201 Autologous T cellsPhase 2 · Relapsed, Refractory Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- RAPA-201 Rapamycin Resistant T CellsPhase 2 · Malignant Melanoma With MetastasisClinicalTrials.gov · fetched Nov 12, 2026
- RAPA-201 Rapamycin Resistant T CellsPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- RAPA-501-Allo off-the-shelf Therapy of COVID-19Phase 2 · Severe COVID-19 DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 MelanomaPHASE2 · NOT_YET_RECRUITING · started Mar 1, 2027ClinicalTrials.gov NCT06708455 · fetched Nov 12, 2026
- RAPA-501 Therapy for ALSPHASE2_PHASE3 · RECRUITING · started Jan 2, 2025ClinicalTrials.gov NCT04220190 · fetched Nov 12, 2026
- RAPA-201 Therapy of Solid TumorsPHASE1_PHASE2 · RECRUITING · started Aug 1, 2021ClinicalTrials.gov NCT05144698 · fetched Nov 12, 2026
- RAPA-501-Allo Therapy of COVID-19-ARDSPHASE1_PHASE2 · TERMINATED · started Dec 30, 2020ClinicalTrials.gov NCT04482699 · fetched Nov 12, 2026
- RAPA-201 T Cell Therapy for Relapsed, Refractory Multiple MyelomaPHASE2 · COMPLETED · started Dec 2, 2020ClinicalTrials.gov NCT04176380 · fetched Nov 12, 2026
- RAPA-501 Therapy of ALS Expanded Access ProtocolTEMPORARILY_NOT_AVAILABLEClinicalTrials.gov NCT06169176 · fetched Nov 12, 2026